Chase Investment Counsel’s Catalyst Pharmaceutical CPRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$1.17M	Hold	54,000	–	–	0.37%	61
2025 Q1	$1.31M	Hold	54,000	–	–	0.48%	57
2024 Q4	$1.13M	Buy	+54,000	New	+$1.13M	0.36%	64